Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1966 2
1967 2
1968 5
1969 2
1970 10
1971 1
1972 1
1973 4
1974 2
1975 4
1976 12
1977 24
1978 16
1979 14
1980 26
1981 28
1982 58
1983 51
1984 52
1985 60
1986 66
1987 75
1988 69
1989 84
1990 84
1991 83
1992 89
1993 57
1994 55
1995 71
1996 54
1997 64
1998 54
1999 41
2000 54
2001 43
2002 41
2003 20
2004 24
2005 29
2006 40
2007 31
2008 30
2009 27
2010 22
2011 22
2012 22
2013 32
2014 27
2015 15
2016 19
2017 18
2018 12
2019 8
2020 6
2021 9
2022 10
2023 7
2024 3
2025 7
2026 4

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,852 results

Results by year

Filters applied: . Clear all
Page 1
Comparing intralesional triamcinolone and verapamil-triamcinolone injections in keloids: A single-blinded randomised clinical trial.
Haghani-Dogahe Z, Hadadi R, Esmailzadeh M, Mobayen M. Haghani-Dogahe Z, et al. Int Wound J. 2023 Dec;20(10):4166-4174. doi: 10.1111/iwj.14314. Epub 2023 Sep 5. Int Wound J. 2023. PMID: 37670475 Free PMC article. Clinical Trial.
INTRODUCTION: In this clinical trial, we investigated the efficacy of two treatment methods for keloids resulting from surgical incisions: intralesional triamcinolone injections alone versus in combination with verapamil. MATERIAL AND METHODS: Patients were divided into tw …
INTRODUCTION: In this clinical trial, we investigated the efficacy of two treatment methods for keloids resulting from surgical incisions: i …
Verapamil in migraine prophylaxis--a five-year review.
Solomon GD. Solomon GD. Headache. 1989 Jul;29(7):425-7. doi: 10.1111/j.1526-4610.1989.hed2907425.x. Headache. 1989. PMID: 2668225 Review.
Verapamil is a papaverine derivative calcium channel blocking drug that has been effectively utilized in the prophylaxis of migraine. ...Analysis of this information reveals that verapamil is a safe, well-tolerated and effective agent for migraine prophylaxis....
Verapamil is a papaverine derivative calcium channel blocking drug that has been effectively utilized in the prophylaxis of migraine.
Pharmacokinetics of calcium channel blocking agents.
Anderson P. Anderson P. Acta Pharmacol Toxicol (Copenh). 1986;58 Suppl 2:43-57. doi: 10.1111/j.1600-0773.1986.tb02520.x. Acta Pharmacol Toxicol (Copenh). 1986. PMID: 2940799 Review.
Verapamil and nifedipine are the most frequently used calcium channel blocking agents in Sweden at present time. The pharmacokinetics of verapamil has been described both in healthy volunteers as well as in patients with supraventricular arrhythmias, angina pectoris
Verapamil and nifedipine are the most frequently used calcium channel blocking agents in Sweden at present time. The pharmacokinetics
Verapamil. An updated review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in hypertension.
McTavish D, Sorkin EM. McTavish D, et al. Drugs. 1989 Jul;38(1):19-76. doi: 10.2165/00003495-198938010-00003. Drugs. 1989. PMID: 2670511 Review.
Although verapamil is a well-established treatment for angina, cardiac arrhythmias and cardiomyopathies, this review reflects current interest in calcium antagonists as anti-hypertensive agents by focusing on the role of verapamil in hypertension. ...Sustained relea …
Although verapamil is a well-established treatment for angina, cardiac arrhythmias and cardiomyopathies, this review reflects current …
Verapamil and ventricular tachyarrhythmias.
Nguyen NX, Yang PT, Huycke E, Sung RJ. Nguyen NX, et al. Pacing Clin Electrophysiol. 1987 May;10(3 Pt 1):571-8. doi: 10.1111/j.1540-8159.1987.tb04522.x. Pacing Clin Electrophysiol. 1987. PMID: 2440008 Review. No abstract available.
Antimanic effects of verapamil.
Giannini AJ, Houser WL Jr, Loiselle RH, Giannini MC, Price WA. Giannini AJ, et al. Am J Psychiatry. 1984 Dec;141(12):1602-3. doi: 10.1176/ajp.141.12.1602. Am J Psychiatry. 1984. PMID: 6439057 Clinical Trial.
When the authors compared the antimanic effects of verapamil, lithium carbonate, and placebo, no differences were seen between lithium and verapamil and both were more effective than placebo in reducing symptoms. ...
When the authors compared the antimanic effects of verapamil, lithium carbonate, and placebo, no differences were seen between lithiu …
Intranasal verapamil in allergen-induced rhinitis.
Secher C, Brofeldt S, Mygind N. Secher C, et al. Allergy. 1983 Nov;38(8):565-70. doi: 10.1111/j.1398-9995.1983.tb04141.x. Allergy. 1983. PMID: 6660435 Clinical Trial.
Twenty-six pollen-allergic subjects participated in a double-blind, placebo-controlled trial of the protective effect of the calcium antagonist, verapamil, on allergen-provoked nasal symptoms. Intranasal verapamil, 1 mg. had a weak protective effect in that "ticklin …
Twenty-six pollen-allergic subjects participated in a double-blind, placebo-controlled trial of the protective effect of the calcium antagon …
Clinical and biochemical effects of verapamil administration to schizophrenic patients.
Pickar D, Wolkowitz OM, Doran AR, Labarca R, Roy A, Breier A, Narang PK. Pickar D, et al. Arch Gen Psychiatry. 1987 Feb;44(2):113-8. doi: 10.1001/archpsyc.1987.01800140015002. Arch Gen Psychiatry. 1987. PMID: 3545130 Clinical Trial.
Verapamil and its active metabolite, norverapamil, were partitioned into CSF with CSF/plasma ratios of 0.06 and 0.04, respectively. The lack of therapeutic effects of verapamil in schizophrenic patients differs from earlier reports of its usefulness in treating mani
Verapamil and its active metabolite, norverapamil, were partitioned into CSF with CSF/plasma ratios of 0.06 and 0.04, respectively. T
Topical verapamil and episcleral venous pressure.
Abreu MM, Kim YY, Shin DH, Netland PA. Abreu MM, et al. Ophthalmology. 1998 Dec;105(12):2251-5. doi: 10.1016/S0161-6420(98)91224-6. Ophthalmology. 1998. PMID: 9855155 Clinical Trial.
After a 2-week administration of topical verapamil, the IOP decreased by 12% (P = 0.0001) in the treated eyes and by 7.2% (P = 0.0289) in the fellow eyes. ...No systemic effect on HR or BP was detected after a single-dose administration of topical verapamil. There w …
After a 2-week administration of topical verapamil, the IOP decreased by 12% (P = 0.0001) in the treated eyes and by 7.2% (P = 0.0289 …
Clinical results of the Verapamil inHypertension and Atherosclerosis Study. VHAS Investigators.
Rosei EA, Dal Palù C, Leonetti G, Magnani B, Pessina A, Zanchetti A. Rosei EA, et al. J Hypertens. 1997 Nov;15(11):1337-44. doi: 10.1097/00004872-199715110-00019. J Hypertens. 1997. PMID: 9383184 Clinical Trial.

Normalization of the diastolic blood pressure (to < or = 90 mmHg or to < or = 95 mmHg with a > or = 10% decrease) was achieved for 69.3% of the verapamil and 66.9% of the chlorthalidone group. A decrease in heart rate (by 5.8%) occurred in members of the verapa

Normalization of the diastolic blood pressure (to < or = 90 mmHg or to < or = 95 mmHg with a > or = 10% decrease) was achieved for

1,852 results